Cancer Res Treat.  2006 Jun;38(3):184-188.

Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 2Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • 3Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea.
  • 5Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. jeunghc1123@yumc.yonsei.ac.kr

Abstract

Surgical resection of colorectal cancer metastasis to the liver results in a 5-year survival rate of around 40%. Liver metastasis from other cancers such as neuroendocrine carcinoma and genitourinary tumors are also treated effectively with combined liver resection. However, hepatic metastasectomy for liver tumor from gastric cancer hasn't been considered as a standard treatment, and the benefit for this treatment has not been established. We report here on two cases of gastrectomy and combined liver resection for synchronous liver metastasis without any evidence of other metastatic lesions, and these two patients have survived for more than 7 years without evidence of disease recurrence. In conclusion, for patients with hepatic metastasis from gastric cancer, combined surgical resection of the liver metastasis should be considered as a treatment option when metastasis to other sites can be excluded.

Keyword

Stomach neoplasms; Liver resection; Long-term survival

MeSH Terms

Carcinoma, Neuroendocrine
Colorectal Neoplasms
Gastrectomy
Humans
Liver*
Metastasectomy
Neoplasm Metastasis*
Recurrence
Stomach Neoplasms*
Survival Rate

Figure

  • Fig. 1 The macroscopic and microscopic finding of the first case. (A) and (B), gross findings of the gastrectomized stomach showing an ulcerofungating mass (arrow) that measured 3.5×4.0 cm on the posterior wall of the antrum. (C) Poorly differentiated adenocarcinoma with lymphocytic infiltrates in the surrounding stroma of the stomach (H&E, ×40). (D) Microscopic findings of the metastatic adenonocarcinoma of the liver (H&E, ×40).

  • Fig. 2 The macroscopic and microscopic findings of the second case. (A) Removed stomach and spleen with a 7×9 cm sized ulcerative lesion on the posterior wall of the cardia and upper body. (B) The resected segment 8 of the liver showing a well-circumscribed 4×4 cm sized, friable gray tan nodular area on the cut section. It grossly abuts to one of the surgical margins. (C) Moderately differentiated adenocarcinoma of stomach (H&E, ×40). (D) Metastatic adenocarcinoma of the liver (H&E, ×40).


Reference

1. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg. 1994; 81:1175–1178. PMID: 7953354.
Article
2. Yoshikawa K, Kitaoka H. Clinicopathologic studies of gastric cancer with metastasis to the liver: based on the case detected at initial surgery. Jpn Clin Oncol. 1984; 14:81–86.
3. Okuyama K, Isono K, Juan IK, Onoda S, Ochiai T, Yamamoto Y, et al. Evaluation of treatment for gastric cancer with liver metastasis. Cancer. 1985; 55:2498–2505. PMID: 3986746.
Article
4. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995; 19:59–71. PMID: 7740812.
Article
5. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg. 1997; 173:467–471. PMID: 9207156.
Article
6. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg. 1999; 86:332–337. PMID: 10201774.
Article
7. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000; 231:487–499. PMID: 10749608.
8. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg. 2001; 181:153–159. PMID: 11425058.
Article
9. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994; 116:703–710. PMID: 7940169.
10. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol. 1997; 92:490–493. PMID: 9068476.
11. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002; 235:86–91. PMID: 11753046.
Article
12. Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol. 2001; 96:3178–3184. PMID: 11721768.
Article
13. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, et al. Benefit and limits of hepatic resection for gastric metastasis. Am J Surg. 2001; 181:279–283. PMID: 11376587.
14. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003; 133:507–511. PMID: 12773978.
Article
15. Roh HR, Suh KS, Lee HJ, Yang HK, Choe KJ, Lee KU. Outcome of hepatic resection for metastatic gastric cancer. Am Surg. 2005; 71:95–99. PMID: 16022005.
Article
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr